Xcovery

Xcovery a biopharmaceutical company discovering and developing medicines to fight advanced tumors. It works on a pipeline of oncology therapies to target a range of malignant diseases. It develops a product, ensartinib (X-396), a small molecule that inhibits anaplastic lymphoma kinase (ALK).